Tesa Research Inc.

The project addresses a high-utility domain by proposing AI and ML for cancer research. However, the submission provides zero verifiable evidence and makes highly improbable claims (e.g., 'most people have used my product') for a 6-person startup launched in 2023. The absence of concrete technical details, unrealistic traction claims, and overall poor response quality trigger significant penalties and the lowest possible quality multipliers.